Ten Moving Targets: 2022Q1
Target-driven drug discovery evolves over time and is influenced by understanding of disease biology, technical innovation, and most of all, clinical data. Our new series reviews drug targets with significant recent clinical data or industry events that have influenced or changed recent perceptions of them. Here we look at 10 targeted agents with indications in oncology, immunology, and other diseases with:
interesting new clinical readouts
significant updated regulatory actions
start-up launches or other recent news
that make these targets worth taking a closer look at.
Loading...